Xylazine and Opioid Overdoses Spur Government Action
Since the beginning of the COVID-19 pandemic, a disruption in access to opioid use disorder (OUD) treatment and recovery services, as well as increased social isolation and stress, contributed to a new surge of overdose deaths. The emergence of illicit falsified prescriptions containing synthetic opioids, notably fentanyl, has contributed to this crisis. Amid these continued […]
Read More ›What Trading Partners Need to Know Before the DSCSA Deadline
Full implementation of the Drug Supply Chain Security Act (DSCSA) was to begin on November 27, 2023. However, on August 25, 2023, US Food & Drug Administration (FDA) issued what it refers to as a “Stabilization Policy,” — a one-year period of non-enforcement for certain DSCSA requirements. In our view, FDA expects drug supply chain […]
Read More ›How Trading Partners Can Prepare for DSCSA
As the DSCSA interoperability deadline approaches, we at NABP remain focused on critical Drug Supply Chain Security Act (DSCSA) infrastructure and committed to helping align all sectors of the supply chain that support and provide safe medication to patients in the United States. This is the fourth blog of a series that explores steps we […]
Read More ›How the Industry Can Enable a Realistic Adoption to DSCSA Compliance
As the DSCSA interoperability deadline approaches, we at NABP remain focused on critical Drug Supply Chain Security Act (DSCSA) infrastructure and committed to helping align all sectors of the supply chain that support and provide safe medication to patients in the United States. This is the third blog of a series that explores steps we […]
Read More ›NABP Supports a Flexible Approach to DSCSA Digital Credentials
As the DSCSA interoperability deadline approaches, we at NABP remain focused on critical Drug Supply Chain Security Act (DSCSA) infrastructure and committed to helping align all sectors of the supply chain that support and provide safe medication to patients in the United States. This is the second blog of a series that explores steps we […]
Read More ›The 4 Biggest Hurdles to DSCSA Compliance
As the DSCSA interoperability deadline approaches, we at NABP remain focused on critical Drug Supply Chain Security Act (DSCSA) infrastructure and committed to helping align all sectors of the supply chain that support and provide safe medication to patients in the United States. This is the first blog of a series that explores steps we […]
Read More ›Task Force Update: NABP Initiatives Tackle Medication Errors, New Pharmacy Practice Models
January is a busy time for NABP. We’re preparing for the 119th Annual Meeting in May and mapping out the upcoming year’s goals and initiatives. In addition, we’re continuing to provide guidance and support on the issues that protect patient safety and are of high importance to the boards of pharmacy. These are projects that […]
Read More ›New Bill for Online Platform Accountability Looks Beyond Section 230
As has been reported extensively over the past year, social media companies have come under scrutiny both at the national and international levels for not doing enough to prevent their platforms from being used to facilitate illegal drug sales. Despite reports that many popular platforms have stepped up efforts to police content – both TikTok […]
Read More ›How Pharmacies Can Prep Now for the 2023 DSCSA Requirements
When Food and Drug Administration (FDA) enacted the Drug Supply Chain Security Act (DSCSA) in 2013, it set a 10-year timeline for full implementation. Well, believe it or not, we are just a little more than a year away from that November 2023 deadline. A significant portion of this last milestone requires the entire supply […]
Read More ›Regulatory Agencies Worldwide Are Partnering to Combat Illegal Online Pharmacies
At the end of July, INTERPOL announced the execution of Operation Pangea XV, an annual week of coordinated law enforcement action to combat the illegal sale of medicines and medical products online. From June 23 to June 30, 2022, 94 member countries spanning every continent issued over 200 search warrants and opened over 600 investigations. […]
Read More ›